about
Relevance of prehospital stroke code activation for acute treatment measures in stroke care: a reviewAn emergency clinical pathway for stroke patients--results of a cluster randomised trial (isrctn41456865).Prognostic significance of admission levels of troponin I in patients with acute ischaemic stroke.Specific therapies for ischaemic stroke: rTPA and others.Which model of stroke unit is better for stroke patient management?Update on calcium antagonists in cerebrovascular diseases.Resting state functional thalamic connectivity abnormalities in patients with post-stroke sleep apnoea: a pilot case-control study.Transcranial Doppler in acute hemispheric brain infarction.Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours.Thrombolysis acute ischemic stroke.The concept of combination therapy in acute ischemic stroke.May stroke cause a Complex Sleep Apnea-CompSA?[Italian Acute Stroke Study: hemodilution + drug. Presentation of the protocol]Cognitive training in patients with Alzheimer's disease: findings of a 12-month randomized controlled trial.Dysphagia and Obstructive Sleep Apnea in Acute, First-Ever, Ischemic Stroke.Are stroke cases affected by sleep disordered breathings all the same?Therapeutic window for pharmacological treatment in acute focal cerebral ischemia.Determinants of plasma levels of brain natriuretic peptide after acute ischemic stroke or TIA.Acute ischemic strokes improving during the first 48 hours of onset: predictability, outcome, and possible mechanisms. A comparison with early deteriorating strokes.Emergency and early carotid endarterectomy in patients with acute ischemic stroke selected with a predefined protocol. A prospective pilot study.Posterior circulation infarcts simulating anterior circulation stroke. Perspective of the acute phase.Circadian variation in the frequency of ischemic stroke.Nutritional recommendations for the prevention of ischemic strokeGM1 ganglioside therapy in acute ischemic stroke. Italian Acute Stroke Study--Hemodilution + DrugClinical and prognostic correlates of stroke subtype misdiagnosis within 12 hours from onsetProgressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosisPure motor hemiparesis and sensorimotor stroke. Accuracy of very early clinical diagnosis of lacunar strokesNeuropsychiatric treatments in medieval RomeStroke is best managed by neurologistsTransforming guidelines in routine practiceIs it time to definitely abandon neuroprotection in acute ischemic stroke?Early clinical diagnosis of lacunar strokesTime of action of neuroprotectors plays a role?Evaluation of medical therapies of acute ischemic stroke
P50
Q26991888-27EB5BD1-9CB9-4D64-8F64-3DDB4A9992C5Q33401705-900118F8-3A2B-4E63-96DB-A57C3C1C30F7Q35483503-3F9EA770-162B-4863-87B7-87D53A2483EDQ36121886-2DEC0EFE-7870-4CEB-B7E4-B90C5052930AQ36533168-545659FE-1639-40CE-9FA6-A3C72F11620DQ36724312-5A141B4B-3278-49EE-8AFE-836CDFC7619BQ38693078-DCC67A80-A368-46AB-A7A1-18945490D21EQ39253439-B3472FF0-4D25-4770-B72B-CA4B8902ED38Q39278891-DF52FF79-D461-4743-A231-E7BFF9DDA1F3Q41089905-704E0294-E230-4065-8193-924A7DF8B08CQ41644101-BA07990D-B750-4BB1-BECF-B1D0E60A6852Q44738539-65C793AE-35A5-44C0-AF70-231FB025F85AQ44768455-875B423A-45C9-4919-AA66-C9EEBD79700EQ47591572-3AF9C3DF-11DA-40C7-9D33-356253245BE8Q47668538-3CFDA2E1-B1AE-49DC-A44B-8B9E6E7A5409Q48105528-4556DE53-1793-42F9-99E8-B12616385A58Q48129661-A852541F-F651-45D2-880E-13C6694CB0B2Q48162428-3FC2D8A9-2BB2-4A28-A0E0-41F31C0E1A3CQ48821755-656F10FD-CCC1-40A1-A88C-887AECC0BDB7Q48882813-378D9DB4-E59E-402A-ABC4-807CDF118EA8Q48958920-A20970E0-54F5-4959-BF95-98A498FD309BQ49075785-E27E59CD-0CCD-4D22-AD87-594CE65FC8F4Q61504297-5A57A958-5D70-4DBF-99B1-57A3E32CB675Q69533254-E775CA22-791F-4078-ADEF-A4D2A1C88DB2Q71769862-E7151D95-10AC-4369-A4A6-1ACBB8A6A1E4Q71907387-F452BEFD-7E01-4362-8E53-532B58FF2440Q72670224-CA671493-1A2D-47D8-9AD0-DA26F489E706Q74670328-CB3B4857-CBF8-4BCB-BB30-02411F0E6094Q80027031-B3AB6FE5-3581-4664-B992-4C2782426C7DQ80417877-F4C4B50F-05F8-438C-9BF8-B2EB5161EC7CQ80963921-16137051-BEF9-4694-9021-6698B2C39953Q81757447-EE5DD346-0017-4042-91B9-D20210767422Q84537769-CE30C6FF-1909-424A-95B9-1B8DD0558665Q86524882-A2ADFAFB-D9E3-4AED-8E0A-D4F662657CA1
P50
description
researcher ORCID ID = 0000-0002-2318-9868
@en
wetenschapper
@nl
name
Maria Luisa Sacchetti
@ast
Maria Luisa Sacchetti
@en
Maria Luisa Sacchetti
@es
Maria Luisa Sacchetti
@nl
type
label
Maria Luisa Sacchetti
@ast
Maria Luisa Sacchetti
@en
Maria Luisa Sacchetti
@es
Maria Luisa Sacchetti
@nl
prefLabel
Maria Luisa Sacchetti
@ast
Maria Luisa Sacchetti
@en
Maria Luisa Sacchetti
@es
Maria Luisa Sacchetti
@nl
P106
P1153
7006210641
P21
P31
P496
0000-0002-2318-9868